Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood
NCT ID: NCT01646008
Last Updated: 2015-12-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2012-04-30
2013-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
respiratory
To measure carbon dioxide by capnography and arterial blood
Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.
to measure carbon dioxide by capnography and arterial blood
three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
To measure carbon dioxide by capnography and arterial blood
Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.
to measure carbon dioxide by capnography and arterial blood
three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* COPD patients
Exclusion Criteria
* Pregnant
* Major burns
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital Universitario Getafe
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Susana Arias Rivera
Registered Nurse
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susana Arias-Rivera, Graduate
Role: PRINCIPAL_INVESTIGATOR
Hospital Universitario de Getafe, Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario de Getafe
Getafe, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Carbon dioxide Getafe
Identifier Type: -
Identifier Source: org_study_id